|
|
|
|
| LEADER |
02499nam a2200313 u 4500 |
| 001 |
EB002001816 |
| 003 |
EBX01000000000000001164717 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 245 |
0 |
0 |
|a Osteoporosis
|h Elektronische Ressource
|b assessing the risk of fragility fracture
|c National Clinical Guideline Centre ; commissioned by the National Institute for Health and Clinical Excellence
|
| 246 |
3 |
1 |
|a Osteoporosis
|
| 260 |
|
|
|a London
|b published by the National Clinical Guideline Centre at the Royal College of Physicians
|c 2012, 2012
|
| 300 |
|
|
|a 1 PDF file (97 p.
|b ill.)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a United Kingdom
|
| 653 |
|
|
|a Risk Assessment
|
| 653 |
|
|
|a Osteoporotic Fractures / prevention & control
|
| 653 |
|
|
|a Osteoporosis / prevention & control
|
| 710 |
2 |
|
|a National Clinical Guideline Centre for Acute and Chronic Conditions (Great Britain)
|
| 710 |
2 |
|
|a National Institute for Health and Clinical Excellence (Great Britain)
|
| 710 |
2 |
|
|a Royal College of Physicians of London
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Short clinical guideline
|
| 500 |
|
|
|a "August 2012."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK115323
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a There are a number of therapies and treatments available for the prevention of fragility fractures in people thought to be at risk, or to prevent further fractures in those who have already had one or more fragility fractures. However, identifying who will benefit from preventative treatment is imprecise. A number of risk assessment tools are available to predict fracture incidence over a period of time, and these may be used to aid decision making. These tools are limited in that they may not include all risk factors, or may lack details of some risk factors. Tools are dependent on the accuracy of the epidemiological data used to derive them and tools validated in other populations may not apply to the UK.. Two tools, FRAX and QFracture, are available for use in the UK. It is not clear whether these tools are equally accurate and whether choice of tool should depend on circumstances. This short clinical guideline aims to provide guidance on the selection and use of risk assessment tools in the care of people who may be at risk of fragility fractures in all settings in which NHS care is received
|